North American Enrollment in Clinical Trials: An Emerging Issue for Regulatory Approval.
| Publicado en: | Oncology Pharmacist Vol. 19; no. 1; pp. 1 - 2 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
Amplity Health
Jan2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194829661&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 194829661 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 19449607 FU65 jtl: Oncology Pharmacist issn: 19449607 maglogo: N pubinfo: dt: Jan2026 vid: 19 iid: 1 pid: 82137 pub: Amplity Health place: East Windsor, New Jersey artinfo: ui: 194829661 194829661 ppf: 1 ppct: 1 formats: fmt: @attributes: type: T tig: atl: North American Enrollment in Clinical Trials: An Emerging Issue for Regulatory Approval. aug: au: Ming-Hei Tai affil: Oncology Pharmacist, Corewell Health William Beaumont University Hospital, Royal Oak, MI. sug: subj: Clinical Trials Research Subject Recruitment Legislation and Jurisprudence Oncology Government Regulations Cancer Patients Patient Selection Americans Drug Approval United States Food and Drug Administration Study Design United States Drug Efficacy Evaluation Patient Safety Evaluation Control Group Crossover Design Committees Lymphoma, B-Cell Drug Therapy Antibodies, Monoclonal Therapeutic Use Gemcitabine Therapeutic Use Oxaliplatin Therapeutic Use Rituximab Therapeutic Use Antineoplastic Agents, Combined Therapeutic Use Overall Survival Progression-Free Survival Asians North Americans Cell Therapy Immunotherapy T Lymphocytes pubtype: Periodical doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|